Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,309 | 6 | 73.8% |
| Travel and Lodging | $24,472 | 7 | 25.7% |
| Food and Beverage | $542.34 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TransMedics, Inc. | $66,066 | 4 | $0 (2024) |
| Astellas Pharma Inc | $16,906 | 5 | $0 (2019) |
| Vertex Pharmaceuticals Incorporated | $11,809 | 4 | $0 (2022) |
| Gilead Sciences, Inc. | $161.12 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $118.46 | 1 | $0 (2024) |
| Ethicon US, LLC | $117.30 | 1 | $0 (2022) |
| Davol Inc. | $51.96 | 1 | $0 (2023) |
| Veloxis Pharmaceuticals, Inc. | $50.00 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.50 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,245 | 2 | TransMedics, Inc. ($1,127) |
| 2023 | $50,589 | 4 | TransMedics, Inc. ($50,439) |
| 2022 | $17,600 | 7 | TRANSMEDICS, INC. ($14,501) |
| 2021 | $2,543 | 1 | Vertex Pharmaceuticals Incorporated ($2,543) |
| 2019 | $23,347 | 7 | Astellas Pharma Inc ($16,906) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | TransMedics, Inc. | Organ Care System (Device) | Travel and Lodging | Cash or cash equivalent | $1,126.54 | General |
| Category: Device | ||||||
| 01/24/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Oncology | ||||||
| 11/02/2023 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $51.96 | General |
| Category: Surgery | ||||||
| 10/18/2023 | TransMedics, Inc. | Organ Care System (Device) | Travel and Lodging | Cash or cash equivalent | $439.00 | General |
| Category: Device | ||||||
| 06/04/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $97.97 | General |
| 04/18/2023 | TransMedics, Inc. | Organ Care System (Device) | Consulting Fee | Stock, stock option, or any other ownership interest | $50,000.00 | General |
| Category: Device | ||||||
| 09/20/2022 | TRANSMEDICS, INC. | ORGAN CARE SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $14,500.55 | General |
| Category: DEVICE | ||||||
| 09/20/2022 | Ethicon US, LLC | Enseal (Device), Echelon Flex, SURGICEL NU-KNIT | Food and Beverage | In-kind items and services | $117.30 | General |
| Category: Energy | ||||||
| 08/06/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunosuppresant | ||||||
| 07/30/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.92 | General |
| 07/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.23 | General |
| 01/12/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $2,825.00 | General |
| 05/26/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $2,542.50 | General |
| 11/29/2019 | Astellas Pharma Inc | TACROLIMUS (Drug) | Consulting Fee | Cash or cash equivalent | $8,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2019 | Astellas Pharma Inc | TACROLIMUS (Drug) | Travel and Lodging | Cash or cash equivalent | $5,865.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2019 | Astellas Pharma Inc | TACROLIMUS (Drug) | Travel and Lodging | Cash or cash equivalent | $1,831.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2019 | Astellas Pharma Inc | TACROLIMUS (Drug) | Travel and Lodging | In-kind items and services | $454.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2019 | Astellas Pharma Inc | TACROLIMUS (Drug) | Travel and Lodging | In-kind items and services | $253.82 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 06/25/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $441.67 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 65 | 207 | $32,695 | $8,667 |
| 2022 | 2 | 62 | 185 | $41,998 | $8,899 |
| 2021 | 4 | 128 | 249 | $178,170 | $34,814 |
| 2020 | 4 | 131 | 316 | $432,022 | $59,086 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 65 | 207 | $32,695 | $8,667 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 100 | $28,440 | $6,095 | 21.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 85 | $13,558 | $2,805 | 20.7% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 12 | 12 | $121,738 | $22,934 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 89 | $26,039 | $5,535 | 21.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 52 | 131 | $20,960 | $4,345 | 20.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $9,433 | $2,000 | 21.2% |
| 47135 | Transplantation of donor liver to anatomic position | Facility | 2020 | 14 | 14 | $358,339 | $43,197 | 12.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 51 | 174 | $27,483 | $5,913 | 21.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 94 | $27,462 | $5,903 | 21.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 34 | $18,738 | $4,073 | 21.7% |
About Dr. James Markmann, MD
Dr. James Markmann, MD is a Transplant Surgery healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861422974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Markmann, MD has received a total of $95,323 in payments from pharmaceutical and medical device companies, with $1,245 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($70,309).
As a Medicare-enrolled provider, Markmann has provided services to 386 Medicare beneficiaries, totaling 957 services with total Medicare billing of $111,466. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Other Specialties Surgery
- Location Philadelphia, PA
- Active Since 07/04/2006
- Last Updated 03/22/2024
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1861422974
Products in Payments
- Organ Care System (Device) $51,566
- TACROLIMUS (Drug) $16,906
- ORGAN CARE SYSTEM (Device) $14,501
- THYMOGLOBULIN (Biological) $118.46
- Enseal (Device) $117.30
- Phasix Mesh (Device) $51.96
- Envarsus (Drug) $50.00
- LIVTENCITY (Drug) $43.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Philadelphia
Dr. Adam Bodzin, M.d, M.D
Transplant Surgery — Payments: $118,715
Kenneth Margulies, Md, MD
Transplant Surgery — Payments: $32,615
Kenneth Chavin, Md, Phd, MD, PHD
Transplant Surgery — Payments: $14,584
Dr. Antonio Di Carlo, Md, MD
Transplant Surgery — Payments: $12,920
Dr. Kwan Nang Lau, M.d, M.D
Transplant Surgery — Payments: $12,442
Gary Xiao, Md, MD
Transplant Surgery — Payments: $11,083